Serum uric acid is associated with increased risk of idiopathic venous thromboembolism in high HDL-C population: A case-control study

Yu,Miao; Ling,Ken; Teng,Yunfei; Li,Qin; Mei,Fei; Li,Yiqing; Ouyang,Chenxi

doi:10.3892/etm.2016.3228

Serum uric acid is associated with increased risk of idiopathic venous thromboembolism in high HDL-C population: A case-control study

Authors:
- Miao Yu
- Ken Ling
- Yunfei Teng
- Qin Li
- Fei Mei
- Yiqing Li
- Chenxi Ouyang
View Affiliations

Affiliations: Department of Vascular Surgery, Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China, Department of Vascular Surgery, Yichang Central People's Hospital, The First College of Clinical Medical Sciences, Three Gorges University, Yichang, Hubei 443003, P.R. China, Department of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, P.R. China
Published online on: April 5, 2016 https://doi.org/10.3892/etm.2016.3228
Pages: 2314-2320
Copyright: © Yu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Many studies have indicated that metabolic disorders are positively correlated with idiopathic venous thromboembolism (VTE), whereas the risk factor serum uric acid (SUA) for idiopathic VTE has yet to be investigated. In this retrospective case-control study, 276 idiopathic VTE patients and 536 gender- and age-matched control subjects were included. The subjects in the case and control groups exhibiting common known VTE risk factors and the patients with a first VTE onset in one month were excluded. For the control group, primary and secondary VTE patients were excluded. High‑density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, total cholesterol, fasting blood glucose, and current smoking were significantly associated with idiopathic VTE in the univariate analysis. Hyperuricemia was detected in 56/276 (20.29%) idiopathic patients compared with 71/536 (13.25%) in the control group. HDL‑C was considered the most prominent interactive factor for SUA in idiopathic VTE by the interaction analysis. After testing for the interaction terms, SUA was closely associated with idiopathic VTE in the high HDL‑C population (P=0.0026 for interaction), while there was no such correlation in the low HDL‑C group. The results indicated no obvious correlation between triglyceride and hypertension to idiopathic VTE. In conclusion, SUA is closely associated with an increased risk of idiopathic VTE in the high HDL‑C population. The abnormality of SUA may act as an important linkage between atherosclerosis and idiopathic VTE through HDL-C.

View Figures

View References

1	Kearon C: Epidemiology of venous thromboembolism. Semin Vasc Med. 1:7–26. 2001. View Article : Google Scholar : PubMed/NCBI
2	Heit JA: Venous thromboembolism epidemiology: Implications for prevention and management. Semin Thromb Hemost. 28(Suppl 2): 3–13. 2002. View Article : Google Scholar : PubMed/NCBI
3	van der Stoep M, Korporaal SJ and Van Eck M: High-density lipoprotein as a modulator of platelet and coagulation responses. Cardiovasc Res. 103:362–371. 2014. View Article : Google Scholar : PubMed/NCBI
4	Brækkan SK, Hald EM, Mathiesen EB, Njølstad I, Wilsgaard T, Rosendaal FR and Hansen JB: Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: The Tromso study. Arterioscler Thromb Vasc Biol. 32:487–491. 2012. View Article : Google Scholar : PubMed/NCBI
5	Deguchi H, Pecheniuk NM, Elias DJ, Averell PM and Griffin JH: High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men. Circulation. 112:893–899. 2005. View Article : Google Scholar : PubMed/NCBI
6	Ageno W, Becattini C, Brighton T, Selby R and Kamphuisen PW: Cardiovascular risk factors and venous thromboembolism: A meta-analysis. Circulation. 117:93–102. 2008. View Article : Google Scholar : PubMed/NCBI
7	Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, et al: A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med. 360:1851–1861. 2009. View Article : Google Scholar : PubMed/NCBI
8	Steffen LM, Cushman M, Peacock JM, Heckbert SR, Jacobs DR Jr, Rosamond WD and Folsom AR: Metabolic syndrome and risk of venous thromboembolism: Longitudinal investigation of thromboembolism etiology. J Thromb Haemost. 7:746–751. 2009. View Article : Google Scholar : PubMed/NCBI
9	Zhao G, Huang L, Song M and Song Y: Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies. Atherosclerosis. 231:61–68. 2013. View Article : Google Scholar : PubMed/NCBI
10	Eichinger S, Pecheniuk NM, Hron G, Deguchi H, Schemper M, Kyrle PA and Griffin JH: High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation. 115:1609–1614. 2007. View Article : Google Scholar : PubMed/NCBI
11	Umaerus M, Rosengren B, Fagerberg B, Hurt-Camejo E and Camejo G: HDL2 interferes with LDL association with arterial proteoglycans: A possible athero-protective effect. Atherosclerosis. 225:115–120. 2012. View Article : Google Scholar : PubMed/NCBI
12	Mineo C, Deguchi H, Griffin JH and Shaul PW: Endothelial and antithrombotic actions of HDL. Circ Res. 98:1352–1364. 2006. View Article : Google Scholar : PubMed/NCBI
13	Asselbergs FW, Williams SM, Hebert PR, Coffey CS, Hillege HL, Navis G, Vaughan DE, van Gilst WH and Moore JH: Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits. J Thromb Haemost. 5:313–320. 2007. View Article : Google Scholar : PubMed/NCBI
14	Numa S, Hirai T, Nakagawa K, Ohara K, Fukuda N, Nozawa T and Inoue H: Hyperuricemia and transesophageal echocardiographic thromboembolic risk in patients with atrial fibrillation at clinically low-intermediate risk. Circ J. 78:1600–1605. 2014. View Article : Google Scholar : PubMed/NCBI
15	Tang RB, Dong JZ, Yan XL, Du X, Kang JP, Wu JH, Yu RH, Long DY, Ning M, Sang CH, et al: Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol. 30:1415–1421. 2014. View Article : Google Scholar : PubMed/NCBI
16	Feig DI, Kang DH and Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med. 359:1811–1821. 2008. View Article : Google Scholar : PubMed/NCBI
17	Zhang Y, Xu RX, Li S, Zhu CG, Guo YL, Sun J and Li JJ: Lipoprotein subfractions partly mediate the association between serum uric acid and coronary artery disease. Clin Chim Acta. 441:109–114. 2015. View Article : Google Scholar : PubMed/NCBI
18	Martin SS, Jones SR and Toth PP: High-density lipoprotein subfractions: Current views and clinical practice applications. Trends Endocrinol Metab. 25:329–336. 2014. View Article : Google Scholar : PubMed/NCBI
19	Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, et al: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 290:F625–F631. 2006. View Article : Google Scholar : PubMed/NCBI
20	Zapolski T, Waciński P, Kondracki B, Rychta E, Buraczyńska MJ and Wysokiński A: Uric acid as a link between renal dysfunction and both pro-inflammatory and prothrombotic state in patients with metabolic syndrome and coronary artery disease. Kardiol Pol. 69:319–326. 2011.PubMed/NCBI
21	Barua RS and Ambrose JA: Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol. 33:1460–1467. 2013. View Article : Google Scholar : PubMed/NCBI
22	Sweetland S, Parkin L, Balkwill A, Green J, Reeves G and Beral V: Million Women Study Collaborators: Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study. Circulation. 127:1276–1282. 2013. View Article : Google Scholar : PubMed/NCBI
23	Enga KF, Braekkan SK, Hansen-Krone IJ, le Cessie S, Rosendaal FR and Hansen JB: Cigarette smoking and the risk of venous thromboembolism: The Tromsø Study. J Thromb Haemost. 10:2068–2074. 2012. View Article : Google Scholar : PubMed/NCBI
24	Blondon M, Wiggins KL, McKnight B, Psaty BM, Rice KM, Heckbert SR and Smith NL: The association of smoking with venous thrombosis in women. A population-based, case-control study. Thromb Haemost. 109:891–896. 2013. View Article : Google Scholar : PubMed/NCBI
25	Blondon M, Wiggins KL, Van Hylckama Vlieg A, McKnight B, Psaty BM, Rice KM, Heckbert SR and Smith NL: Smoking, postmenopausal hormone therapy and the risk of venous thrombosis: A population-based, case-control study. Br J Haematol. 163:418–420. 2013. View Article : Google Scholar : PubMed/NCBI
26	Woodward M, Lowe GD, Rumley A, Tunstall-Pedoe H, Philippou H, Lane DA and Morrison CE: Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey. II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 97:785–797. 1997. View Article : Google Scholar : PubMed/NCBI
27	Sun GZ, Li Z, Guo L, Zhou Y, Yang HM and Sun YX: High prevalence of dyslipidemia and associated risk factors among rural Chinese adults. Lipids Health Dis. 13:1892014. View Article : Google Scholar : PubMed/NCBI
28	Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al: China National Diabetes and Metabolic Disorders Study Group: Prevalence of diabetes among men and women in China. N Engl J Med. 362:1090–1101. 2010. View Article : Google Scholar : PubMed/NCBI
29	Gao B, Zhou J, Ge J, Zhang Y, Chen F, Lau WB, Wan Y, Zhang N, Xing Y, Wang L, et al: Association of maximum weight with hyperuricemia risk: A retrospective study of 21,414 Chinese people. PLoS One. 7:e511862012. View Article : Google Scholar : PubMed/NCBI